Ezypod-100

Cefpodoxime Proxetil 100 mg

Mechanism of Action

Cefpodoxime Proxetil is a prodrug that is converted in vivo to cefpodoxime,
which inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.

This leads to bacterial cell lysis and death, making it effective against
a wide range of Gram-positive and Gram-negative bacteria.

Indications

• Upper respiratory tract infections
• Lower respiratory tract infections
• Urinary tract infections
• Skin and soft tissue infections
• Ear, nose, and throat infections

Key Benefits

• Broad-spectrum antibacterial coverage
• Effective against common respiratory and urinary pathogens
• Convenient oral dosing
• Good patient tolerability when used appropriately

Dosage and Administration

Dosage should be as directed by the physician based on the type and severity
of infection. Complete the full course of therapy as prescribed.

Safety Information

• Prescription-only antibiotic
• Use only under medical supervision
• Do not discontinue therapy prematurely
• Caution advised in patients with renal impairment
• Not indicated for viral infections
• Store in a cool and dry place

Clinical Rationale

Ezypod-100 provides effective oral cephalosporin therapy for susceptible
bacterial infections. Its broad coverage and established safety profile
make it a reliable choice in outpatient infection management when prescribed
judiciously.